Acute multi-level response to defective de novo chromatin assembly in S-phase
Molecular Cell · 2024
DOI: 10.1016/j.molcel.2024.10.023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2024. Verfasst von Jan Dreyer und 22 weiteren Autor:innen. Beteiligte Einrichtung: Hubrecht Institute, KNAW & University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Chromatin Assembly and Disassembly, DNA Replication, Histones, S Phase. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Long-term perturbation of de novo chromatin assembly during DNA replication has profound effects on epigenome maintenance and cell fate. The early mechanistic origin of these defects is unknown. Here, we combine acute degradation of chromatin assembly factor 1 (CAF-1), a key player in de novo chromatin assembly, with single-cell genomics, quantitative proteomics, and live microscopy to uncover these initiating mechanisms in human cells. CAF-1 loss immediately slows down DNA replication speed and renders nascent DNA hyper-accessible. A rapid cellular response, distinct from canonical DNA damage signaling, is triggered and lowers histone mRNAs. In turn, histone variants' usage and their modifications are altered, limiting transcriptional fidelity and delaying chromatin maturation within a single S-phase. This multi-level response induces a p53-dependent cell-cycle arrest after mitosis. Our work reveals the immediate consequences of defective de novo chromatin assembly during DNA replication, indicating how at later times the epigenome and cell fate can be altered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubrecht Institute, KNAW & University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands.
- Hubrecht Institute, KNAW & University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands.
- Department of Biochemistry, University of Colorado Boulder, Boulder, CO 80303, USA; BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303, USA.
- Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
- MOLEQLAR Analytics GmbH, Rosenheimer Street 141 h, 81671 Munich, Germany.
- Oncode Institute, Utrecht, the Netherlands; Division of Gene Regulation, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Department of Biosciences, Università degli Studi di Milano, Vi…
Zitieren
APA
Dreyer, J., Ricci, G., van den Berg, J., Bhardwaj, V., Funk, J., Armstrong, C., van Batenburg, V., Sine, C., VanInsberghe, M. A., Tjeerdsma, R. B., Marsman, R., Mandemaker, I. K., di Sanzo, S., Costantini, J., Manzo, S. G., Biran, A., Burny, C., van Vugt, M. A. T. M., Völker-Albert, M., …, & Mattiroli, F. (2024). Acute multi-level response to defective de novo chromatin assembly in S-phase. Molecular Cell. https://doi.org/10.1016/j.molcel.2024.10.023
Vancouver
Dreyer J, Ricci G, van den Berg J, Bhardwaj V, Funk J, Armstrong C, et al. Acute multi-level response to defective de novo chromatin assembly in S-phase. Molecular Cell. 2024. doi:10.1016/j.molcel.2024.10.023
BibTeX
@article{Dreyer2024,
author = {Dreyer, Jan and Ricci, Giulia and van den Berg, Jeroen and Bhardwaj, Vivek and Funk, Janina and Armstrong, Claire and van Batenburg, Vincent and Sine, Chance and VanInsberghe, Michael A and Tjeerdsma, Rinskje B and Marsman, Richard and Mandemaker, Imke K and di Sanzo, Simone and Costantini, Juliette and Manzo, Stefano G and Biran, Alva and Burny, Claire and van Vugt, Marcel A T M and Völker-Albert, Moritz and Groth, Anja and Spencer, Sabrina L and van Oudenaarden, Alexander and Mattiroli, Francesca},
title = {Acute multi-level response to defective de novo chromatin assembly in S-phase},
journal = {Molecular Cell},
year = {2024},
doi = {10.1016/j.molcel.2024.10.023}
}
EUVIMED